Table 1 Codon usage differences between each cancer and its respective normal tissue
Cancer name | Higher in cancer or normal | Codon | % difference |
|---|---|---|---|
Aggregate transitional cell carcinoma—bladder | Cancer | CGG | 5.42 |
Aggregate transitional cell carcinoma—Bladder | Normal | TGT | 5.23 |
Transitional cell carcinoma—bladder | Cancer | CGG | 4.76 |
Transitional cell carcinoma—bladder | Normal | TGT | 5.03 |
Papillary transitional cell carcinoma—bladder | Cancer | CGG | 8.26 |
Papillary transitional cell carcinoma—bladder | Normal | CCT | 9.28 |
Aggregate carcinoma—breast | Cancer | GGT | 15.83 |
Aggregate carcinoma—breast | Normal | TGT | 7.44 |
Ductal carcinoma—breast | Cancer | GGT | 15.06 |
Ductal carcinoma—breast | Normal | TGT | 7.60 |
Lobular carcinoma—breast | Cancer | GGT | 19.60 |
Lobular carcinoma—breast | Normal | TTA | 8.93 |
Duct and lobular carcinoma—breast | Cancer | GGT | 28.12 |
Duct and lobular carcinoma—breast | Normal | TGT | 5.01 |
Colorectal adenocarcinoma | Cancer | CGT | 11.28 |
Colorectal adenocarcinoma | Normal | TGC | 8.23 |
Left colorectal adenocarcinoma | Cancer | CGT | 11.39 |
Left colorectal adenocarcinoma | Normal | TGC | 7.55 |
Right colorectal adenocarcinoma | Cancer | CGT | 12.23 |
Right colorectal adenocarcinoma | Normal | TGC | 10.40 |
Adenocarcinoma—endometrium | Cancer | GCG | 6.06 |
Adenocarcinoma—endometrium | Normal | CAA | 8.52 |
Endometrioid adenocarcinoma | Cancer | GCG | 6.07 |
Endometrioid adenocarcinoma | Normal | CAA | 9.01 |
Serous cystadenocarcinoma—endometrium | Cancer | GCG | 6.86 |
Serous cystadenocarcinoma—endometrium | Normal | CAA | 7.22 |
Squamous cell carcinoma—head and neck | Cancer | TCC | 6.20 |
Squamous cell carcinoma—head and neck | Normal | CAC | 4.78 |
Squamous cell carcinoma—esophagus | Cancer | CGC | 19.16 |
Squamous cell carcinoma—esophagus | Normal | TAT | 22.41 |
Esophageal adenocarcinoma | Cancer | CGG | 17.63 |
Esophageal adenocarcinoma | Normal | TAT | 18.16 |
Clear cell renal cell carcinoma | Cancer | CGC | 6.67 |
Clear cell renal cell carcinoma | Normal | ATA | 6.57 |
Papillary renal cell carcinoma | Cancer | CGC | 11.36 |
Papillary renal cell carcinoma | Normal | TTA | 13.01 |
Chromophobe renal cell carcinoma | Cancer | CGC | 10.11 |
Chromophobe renal cell carcinoma | Normal | TGC | 10.03 |
Hepatocellular carcinoma | Cancer | CGG | 24.19 |
Hepatocellular carcinoma | Normal | TGT | 28.55 |
Cholangiocarcinoma | Cancer | CGG | 47.48 |
Cholangiocarcinoma | Normal | TGT | 61.40 |
Adenocarcinoma—lung | Cancer | CGT | 11.77 |
Adenocarcinoma—lung | Normal | TGC | 13.07 |
Squamous cell carcinoma—lung | Cancer | CGT | 16.52 |
Squamous cell carcinoma—lung | Normal | TGC | 17.95 |
Adenocarcinoma with mixed subtypes—lung | Cancer | CGT | 11.86 |
Adenocarcinoma with mixed subtypes—lung | Normal | TGT | 12.38 |
Bronchioloalveolar carcinoma | Cancer | TTA | 12.15 |
Bronchioloalveolar carcinoma | Normal | TGC | 10.07 |
Papillary adenocarcinoma—lung | Cancer | CGT | 10.82 |
Papillary adenocarcinoma—lung | Normal | TGT | 11.76 |
Mucinous adenocarcinoma—lung | Cancer | CGG | 8.76 |
Mucinous adenocarcinoma—lung | Normal | CCT | 8.90 |
Prostate adenocarcinoma | Cancer | GGT | 3.74 |
Prostate adenocarcinoma | Normal | ATA | 3.57 |
Adenocarcinoma—stomach | Cancer | TTA | 12.74 |
Adenocarcinoma—stomach | Normal | TGC | 5.62 |
Intestinal type adenocarcinoma—stomach | Cancer | TTA | 12.45 |
Intestinal type adenocarcinoma—stomach | Normal | TGC | 5.82 |
Diffuse type carcinoma—stomach | Cancer | TTA | 13.49 |
Diffuse type carcinoma—stomach | Normal | GTC | 5.68 |
Tubular adenocarcinoma—stomach | Cancer | TTA | 13.51 |
Tubular adenocarcinoma—stomach | Normal | TGC | 6.88 |